SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is driving intense retail and institutional engagement following its major IPO, with the community actively debating whether the stock represents a long-term growth opportunity or a speculative trap built on hype. Investors are closely watching for future volatility, with many users speculating on potential short squeezes, lock-up period impacts, and the stock's eventual valuation reset.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently experiencing high volatility as investors weigh the stock's inclusion in the Nasdaq-100 against broader capital rotation into the long-awaited SpaceX IPO. While some market participants are liquidating existing space sector positions to chase SpaceX, many community members remain focused on Rocket Lab's long-term launch backlog and structural growth as a core pure-play alternative.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is seeing significant investor interest following Bloomberg reports that the company is in early-stage discussions regarding a potential sale to a media firm. While some investors are skeptical due to past rumors and industry competition, others are aggressively bullish, pointing to the company's recent surge in trading volume and the strategic value of its massive streaming household reach as a key catalyst for a potential premium acquisition.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp (SNDK) is experiencing intense volatility and record-breaking momentum, fueled by a combination of strong AI-driven storage demand and aggressive speculative trading. The community remains sharply divided, with bulls pointing to the company's sustained performance and institutional interest, while a vocal contingent of bears warns of a bubble and potential rapid correction.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is experiencing significant volatility and downward pressure as investors re-evaluate its scarcity premium ahead of the highly anticipated SpaceX IPO. The community is actively debating whether the stock is a long-term value play based on its holdings in SpaceX, Anthropic, and OpenAI or a 'sell-the-news' trap worsened by recent share dilution.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

XOVR is trending as investors debate its structural role as a crossover ETF, specifically focusing on its significant exposure to SpaceX's pre-IPO assets. The community is actively weighing the fund's liquidity benefits against concerns over its price stability and the mechanics of its private asset valuations compared to more speculative space-themed plays.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is currently facing significant market volatility as investors react to the R2 launch, with many community members debating whether the stock's recent price movement represents an attractive entry point or continued downward pressure. The conversation is heavily focused on whether management's communication and pricing strategies will successfully convert high product interest into long-term financial performance.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing heavy sell-side pressure as capital rotates into the long-awaited SpaceX IPO, leading to a sector-wide liquidity shakeout across space-related stocks. While some investors are concerned about the downward momentum, others view the pullback as a buying opportunity, emphasizing upcoming satellite launches and the company's established partnerships as core catalysts for long-term recovery.

Powerlaw Corp. is a closed-end fund, which engages in investing in artificial intelligence, next-generation software, modern aerospace and defense, and consumer technology platforms. It offers daily liquidity, monthly NAV reporting, quarterly portfolio disclosure, independent governance, and the disclosure standards of a registered investment company. The company was founded on September 9, 2024 and is headquartered in San Francisco, CA.

Powerlaw Corp

Powerlaw Corp is seeing heightened investor attention as market participants debate the stock's valuation relative to its concentrated exposure in high-profile private companies like SpaceX. While some community members are focused on potential upside from upcoming IPO activity, others are actively expressing frustration regarding extreme price volatility and a disconnect between share price and net asset value.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp. is experiencing intense market focus as a 10-for-1 stock split takes effect alongside surging AI-driven demand for advanced semiconductor manufacturing equipment. While the split and strong revenue guidance have fueled bullish momentum, community sentiment remains sharply divided due to significant insider selling and concerns regarding high valuations versus historical semiconductor cycle patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy

Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy...

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Consensus Rating of "Moderate Buy" by Brokerages

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rat...

Mineralys Therapeutics (MLYS) Projected to Post Earnings on Wednesday

Mineralys Therapeutics (NASDAQ:MLYS) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-mineralys-therapeutics-inc-stock...

Mineralys Therapeutics (NASDAQ:MLYS) Trading 8.2% Higher   - Should You Buy?

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 8.2% - Should You Buy...

Mineralys Therapeutics, Inc. $MLYS Shares Bought by Jennison Associates LLC

Jennison Associates LLC grew its holdings in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 234.4% in the fourth quarter, according to its most recent filing with the...

Pictet Asset Management Holding SA Sells 76,286 Shares of Mineralys Therapeutics, Inc. $MLYS

Pictet Asset Management Holding SA trimmed its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 8.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 852,883 shares of the...

Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap Down - Here's Why

Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap Down - Here's What Happened...

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 416 Shares of Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 416 shares of the business's stock in a transaction that occurred on Friday, April 17th. The shares were...

David Malcom Rodman Sells 416 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 416 shares of the stock in a transaction dated Friday, April 17th. The stock was sold at an average price...

David Malcom Rodman Sells 6,348 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 6,348 shares of Mineralys Therapeutics stock in a transaction dated Wednesday, April 15th. The shares...

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.55	--	--	N/A
Q1 '26	-$0.47	-$0.47	0.46%	BEAT
Q4 '25	-$0.52	-$0.40	22.52%	BEAT
Q3 '25	-$0.61	-$0.52	15.15%	BEAT
Q2 '25	-$0.74	-$0.66	10.64%	BEAT

MLYSMineralys Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest MLYS News